Th1/17 Polarization of CD4 T Cells Supports HIV-1 Persistence during Antiretroviral Therapy

被引:85
|
作者
Sun, Hong [1 ,2 ]
Kim, Dhohyung [1 ]
Li, Xiaodong [1 ]
Kiselinova, Maja [1 ,3 ,4 ]
Ouyang, Zhengyu [1 ]
Vandekerckhove, Linos
Shang, Hong [2 ]
Rosenberg, Eric S. [5 ]
Yu, Xu G. [1 ]
Lichterfeld, Mathias [1 ,5 ,6 ]
机构
[1] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA
[2] China Med Univ, Affiliated Hosp 1, Key Lab AIDS Immunol, Natl Hlth & Family Planning Commiss, Shenyang, Peoples R China
[3] Univ Ghent, HIV Translat Res Unit, B-9000 Ghent, Belgium
[4] Univ Hosp, Ghent, Belgium
[5] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA
[6] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; TRANSCRIPTION FACTOR GATA-3; TH17; CELLS; GENE-EXPRESSION; RESERVOIR; INFECTION; LATENT; DIFFERENTIATION; IDENTIFICATION;
D O I
10.1128/JVI.01595-15
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The ability to persist long term in latently infected CD4 T cells represents a characteristic feature of HIV-1 infection and the predominant barrier to efforts aiming at viral eradication and cure. Yet, increasing evidence suggests that only small subsets of CD4 T cells with specific developmental and maturational profiles are able to effectively support HIV-1 long-term persistence. Here, we analyzed how the functional polarization of CD4 T cells shapes and structures the reservoirs of HIV-1-infected cells. We found that CD4 T cells enriched for a Th1/17 polarization had elevated susceptibilities to HIV-1 infection in ex vivo assays, harbored high levels of HIV-1 DNA in persons treated with antiretroviral therapy, and made a disproportionately increased contribution to the viral reservoir relative to their contribution to the CD4 T memory cell pool. Moreover, HIV-1 DNA levels in Th1/17 cells remained stable over many years of antiretroviral therapy, resulting in a progressively increasing contribution of these cells to the viral reservoir, and phylogenetic studies suggested preferential long-term persistence of identical viral sequences during prolonged antiretroviral treatment in this cell compartment. Together, these data suggest that Th1/17 CD4 T cells represent a preferred site for HIV-1 DNA long-term persistence in patients receiving antiretroviral therapy. IMPORTANCE Current antiretroviral therapy is very effective in suppressing active HIV-1 replication but does not fully eliminate virally infected cells. The ability of HIV-1 to persist long term despite suppressive antiretroviral combination therapy represents a perplexing aspect of HIV-1 disease pathogenesis, since most HIV-1 target cells are activated, short-lived CD4 T cells. This study suggests that CD4 T helper cells with Th1/17 polarization have a preferential role as a long-term reservoir for HIV-1 infection during antiretroviral therapy, possibly because these cells may imitate some of the functional properties traditionally attributed to stem cells, such as the ability to persist for extremely long periods of time and to repopulate their own pool size through homeostatic self-renewal. These observations support the hypothesis that HIV-1 persistence is driven by small subsets of long-lasting stem cell-like CD4 T cells that may represent particularly promising targets for clinical strategies aiming at HIV-1 eradication and cure.
引用
收藏
页码:11284 / 11293
页数:10
相关论文
共 50 条
  • [21] Th1/Th17 gammadelta T cells are expanded in HIV-1 infected patients and respond to Candidaalbicans
    Alessandro Poggi
    Daniela Fenoglio
    Florinda Battaglia
    Silvia Catellani
    Alessandra Musso
    Maurizio Setti
    Giuseppe Murdaca
    Maria Raffaella Zocchi
    Retrovirology, 7
  • [22] HIV-1 Vpr inhibits autophagy during the early steps of infection of CD4 T cells
    Alfaisal, Jamal
    Machado, Alice
    Galais, Mathilde
    Robert-Hebmann, Veronique
    Arnaune-Pelloquin, Laetitia
    Espert, Lucile
    Biard-Piechaczyk, Martine
    BIOLOGY OF THE CELL, 2019, 111 (12) : 308 - 318
  • [23] Efficient HIV-1 Trans Infection of CD4+ T Cells Occurs in the Presence of Antiretroviral Therapy
    Rappocciolo, Giovanna
    Sluis-Cremer, Nicolas
    Rinaldo, Charles R.
    OPEN FORUM INFECTIOUS DISEASES, 2019, 6 (07):
  • [24] CD4 T cells remain the major source of HIV-1 during end stage disease
    van der Ende, ME
    Schutten, M
    Raschdorff, B
    Grossschupff, G
    Racz, P
    Osterhaus, ADME
    Tenner-Racz, K
    AIDS, 1999, 13 (09) : 1015 - 1019
  • [25] Th1 type CD4(+) T cells may be a potent effector against poorly immunogenic syngeneic tumors - Anti-tumor activity of Th1 type CD4(+) T cells
    Terao, H
    Harada, M
    Kurosawa, S
    Shinomiya, Y
    Okamoto, T
    Ito, O
    Sumichika, H
    Takenoyama, M
    Nomoto, K
    BIOTHERAPY, 1995, 8 (02) : 143 - 151
  • [26] Migration of CD4 Th1 T Cells to the Inflamed Intestine Is Suppressed by Netrin-1
    Aherne, Carol
    Rapp, Caroline
    Collins, Colm
    McNamee, Eoin
    Jedlicka, Paul
    Eltzschig, Holger
    INFLAMMATORY BOWEL DISEASES, 2016, 22 : S47 - S48
  • [27] Autophagy and CD4 T lymphocyte destruction by HIV-1
    Espert, Lucile
    Denizot, Melanie
    Grimaldi, Marina
    Robert-Hebmann, Veronique
    Gay, Bernard
    Varbanov, Mihayl
    Codogno, Patrice
    Biard-Piechaczyk, Martine
    M S-MEDECINE SCIENCES, 2006, 22 (8-9): : 677 - 678
  • [28] Clonal expansion of genome-intact HIV-1 in functionally polarized Th1 CD4+ T cells
    Lee, Guinevere Q.
    Orlova-Fink, Nina
    Einkauf, Kevin
    Chowdhury, Fatema Z.
    Sun, Xiaoming
    Harrington, Sean
    Kuo, Hsiao-Hsuan
    Hua, Stephane
    Chen, Hsiao-Rong
    Ouyang, Zhengyu
    Reddy, Kavidha
    Dong, Krista
    Ndung'u, Thumbi
    Walker, Bruce D.
    Rosenberg, Eric S.
    Yu, Xu G.
    Lichterfeld, Mathias
    JOURNAL OF CLINICAL INVESTIGATION, 2017, 127 (07): : 2689 - 2696
  • [29] Persistence of VRC01-resistant HIV-1 during antiretroviral therapy
    DongXing Guo
    XuanLing Shi
    DingKa Song
    LinQi Zhang
    Science China Life Sciences, 2014, 57 : 88 - 96
  • [30] New Insights into HIV-1 Persistence in Sanctuary Sites During Antiretroviral Therapy
    Poveda, Eva
    Tabernilla, Andres
    AIDS REVIEWS, 2016, 18 (01) : 55 - 55